237 related articles for article (PubMed ID: 21199803)
1. Activation and involvement of Ral GTPases in colorectal cancer.
Martin TD; Samuel JC; Routh ED; Der CJ; Yeh JJ
Cancer Res; 2011 Jan; 71(1):206-15. PubMed ID: 21199803
[TBL] [Abstract][Full Text] [Related]
2. Differential involvement of RalA and RalB in colorectal cancer.
Martin TD; Der CJ
Small GTPases; 2012; 3(2):126-30. PubMed ID: 22790202
[TBL] [Abstract][Full Text] [Related]
3. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
[TBL] [Abstract][Full Text] [Related]
4. The RalB small GTPase mediates formation of invadopodia through a GTPase-activating protein-independent function of the RalBP1/RLIP76 effector.
Neel NF; Rossman KL; Martin TD; Hayes TK; Yeh JJ; Der CJ
Mol Cell Biol; 2012 Apr; 32(8):1374-86. PubMed ID: 22331470
[TBL] [Abstract][Full Text] [Related]
5. Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.
Guin S; Ru Y; Wynes MW; Mishra R; Lu X; Owens C; Barn AE; Vasu VT; Hirsch FR; Kern JA; Theodorescu D
J Thorac Oncol; 2013 Dec; 8(12):1492-501. PubMed ID: 24389431
[TBL] [Abstract][Full Text] [Related]
6. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms.
Vigil D; Martin TD; Williams F; Yeh JJ; Campbell SL; Der CJ
J Biol Chem; 2010 Nov; 285(45):34729-40. PubMed ID: 20801877
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamic mapping of effector protein interfaces with RalA and RalB.
Campbell LJ; Peppa M; Crabtree MD; Shafiq A; McGough NF; Mott HR; Owen D
Biochemistry; 2015 Feb; 54(6):1380-9. PubMed ID: 25621740
[TBL] [Abstract][Full Text] [Related]
8. RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer.
Khawaja H; Campbell A; Roberts JZ; Javadi A; O'Reilly P; McArt D; Allen WL; Majkut J; Rehm M; Bardelli A; Di Nicolantonio F; Scott CJ; Kennedy R; Vitale N; Harrison T; Sansom OJ; Longley DB; Evergren E; Van Schaeybroeck S
Cell Death Dis; 2020 Oct; 11(10):930. PubMed ID: 33122623
[TBL] [Abstract][Full Text] [Related]
9. Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis.
Issaq SH; Lim KH; Counter CM
Mol Cancer Res; 2010 Feb; 8(2):223-31. PubMed ID: 20145037
[TBL] [Abstract][Full Text] [Related]
10. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
Falsetti SC; Wang DA; Peng H; Carrico D; Cox AD; Der CJ; Hamilton AD; Sebti SM
Mol Cell Biol; 2007 Nov; 27(22):8003-14. PubMed ID: 17875936
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs.
Cascone I; Selimoglu R; Ozdemir C; Del Nery E; Yeaman C; White M; Camonis J
EMBO J; 2008 Sep; 27(18):2375-87. PubMed ID: 18756269
[TBL] [Abstract][Full Text] [Related]
12. The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
Cooper JM; Bodemann BO; White MA
Enzymes; 2013; 34 Pt. B():137-56. PubMed ID: 25034103
[TBL] [Abstract][Full Text] [Related]
13. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.
Tecleab A; Zhang X; Sebti SM
J Biol Chem; 2014 Nov; 289(45):31296-309. PubMed ID: 25210032
[TBL] [Abstract][Full Text] [Related]
14. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.
Lim KH; O'Hayer K; Adam SJ; Kendall SD; Campbell PM; Der CJ; Counter CM
Curr Biol; 2006 Dec; 16(24):2385-94. PubMed ID: 17174914
[TBL] [Abstract][Full Text] [Related]
15. Expression of ral GTPases, their effectors, and activators in human bladder cancer.
Smith SC; Oxford G; Baras AS; Owens C; Havaleshko D; Brautigan DL; Safo MK; Theodorescu D
Clin Cancer Res; 2007 Jul; 13(13):3803-13. PubMed ID: 17606711
[TBL] [Abstract][Full Text] [Related]
16. RalBP1 is necessary for metastasis of human cancer cell lines.
Wu Z; Owens C; Chandra N; Popovic K; Conaway M; Theodorescu D
Neoplasia; 2010 Dec; 12(12):1003-12. PubMed ID: 21170262
[TBL] [Abstract][Full Text] [Related]
17. The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction.
Fenwick RB; Campbell LJ; Rajasekar K; Prasannan S; Nietlispach D; Camonis J; Owen D; Mott HR
Structure; 2010 Aug; 18(8):985-95. PubMed ID: 20696399
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation by protein kinase Cα regulates RalB small GTPase protein activation, subcellular localization, and effector utilization.
Martin TD; Mitin N; Cox AD; Yeh JJ; Der CJ
J Biol Chem; 2012 Apr; 287(18):14827-36. PubMed ID: 22393054
[TBL] [Abstract][Full Text] [Related]
19. Divergent roles of CAAX motif-signaled posttranslational modifications in the regulation and subcellular localization of Ral GTPases.
Gentry LR; Nishimura A; Cox AD; Martin TD; Tsygankov D; Nishida M; Elston TC; Der CJ
J Biol Chem; 2015 Sep; 290(37):22851-61. PubMed ID: 26216878
[TBL] [Abstract][Full Text] [Related]
20. Activation of RalA is critical for Ras-induced tumorigenesis of human cells.
Lim KH; Baines AT; Fiordalisi JJ; Shipitsin M; Feig LA; Cox AD; Der CJ; Counter CM
Cancer Cell; 2005 Jun; 7(6):533-45. PubMed ID: 15950903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
